WINNIPEG, Dec. 19, 2017 /PRNewswire/ – Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a pharmaceutical company, today announced that Carmel Biosciences, Inc. ("Carmel") has received final approval of its New Drug Application from…Original Article
Medicure Announces FDA Approval Received for Prexxartan (valsartan) Oral Solution
